Identity
- Trade Name
- AMFAB FDA UDI
- Generic Name
- Overbed table FDA UDI
- Device Name
- Patient Room Overbed Tables Product Description OBT-Auto-LrgTpl-QO-U-Ch-Van-SpOr FDA UDI
- Model / Reference
- 16009-UCQOV FDA UDI
- Description
- Patient Room Overbed Tables Product Description OBT-Auto-LrgTpl-QO-U-Ch-Van-SpOr FDA UDI
Identifiers
- Primary DI / UDI-DI
- 00822383236933 FDA UDI
- FDA Product Code
- INW FDA UDI
- GMDN Term
- Overbed table FDA UDI
Classification
- Device Class
- Class I FDA UDI
- Regulation Number
- 890.3750 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
No
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
No
FDA UDI
Over-the-Counter
Yes
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
Yes
FDA UDI
Lot / Batch Number
No
FDA UDI
Serial Number
Yes
FDA UDI
Expiration Date
No
FDA UDI
Manufacturing Date
No
FDA UDI
Category: Overbed table
Amfab by Drive Devilbiss Healthcare — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Overbed table.
- DALTON OVERBED TABLE — Dalton Medical Corp. · Class I
- Plastic Overbed Table — Dynarex Corp. · Class I
- Overbed Table — Dynarex Corp. · Class I
- PROBASICS — COMPASS HEALTH BRANDS CORP. · Class I
- AMFAB — Drive Devilbiss Healthcare · Class I
- AMFAB — Drive Devilbiss Healthcare · Class I
- AMFAB — Drive Devilbiss Healthcare · Class I
- AMFAB — Drive Devilbiss Healthcare · Class I
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class I | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Drive Devilbiss Healthcare
Sources (1)
- FDA UDI 75a95692-273d-4fda-abe9-bb481c168fcb 33 fields · synced Jun 8, 2026